Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05158452 · ClinicalTrials.gov registry record

Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer

A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
8
Enrollment target

NCT05158452 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05158452 has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
8 participants
Enrollment target

Study Summary

This study develops a genetic counseling patient preference intervention for women at elevated risk for breast cancer. This study aims to develop an intervention that may deliver educational videos about breast cancer, heredity, multigene tests results and polygenic risk score, provide multigene and polygenic test results, obtain information about patients' questions/ concerns about test results to use in post-genetic test counseling, and determine patient preference (e.g. telephone) for receipt of post-genetic test counseling.

Interventions

  • PROCEDURE Discussion

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2020-12-09
Est. Completion 2022-10-30

What the Registry Record Tells You About NCT05158452

The ClinicalTrials.gov registry entry for NCT05158452 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Discussion is the first listed.

NCT05158452 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05158452 about?

NCT05158452 is a clinical study titled "Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer". This study develops a genetic counseling patient preference intervention for women at elevated risk for breast cancer. This study aims to develop an intervention that may deliver educational videos about breast cancer, heredity, multigene tests results and polygenic risk score, provide multigene and...

What is the current status of trial NCT05158452?

This trial is currently completed. The enrollment target is 8 participants. The study started on 2020-12-09. Estimated completion is 2022-10-30.

What interventions are being tested in trial NCT05158452?

The interventions under investigation include: Discussion (PROCEDURE).

Who is sponsoring clinical trial NCT05158452?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.